These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32525153)

  • 41. Hitchhiking into a cell: flavonoids may produce complexes with transition metals for transmembrane translocation.
    Tarahovsky YS
    Biometals; 2022 Dec; 35(6):1299-1306. PubMed ID: 36161545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transition metal compounds as cancer radiosensitizers.
    Gill MR; Vallis KA
    Chem Soc Rev; 2019 Jan; 48(2):540-557. PubMed ID: 30499573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
    Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
    Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved cytotoxicity of pyridyl-substituted thiosemicarbazones against MCF-7 when used as metal ionophores.
    Akladios FN; Andrew SD; Parkinson CJ
    Biometals; 2016 Feb; 29(1):157-70. PubMed ID: 26683314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rational Design of Silicon-Based Zinc Ionophores.
    Yamada K; Deb A; Shoba VM; Lim D; Maji B; Modell AE; Choudhary A
    Angew Chem Int Ed Engl; 2022 Jun; 61(23):e202201698. PubMed ID: 35385189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell permeable iron chelators as potential cancer chemotherapeutic agents.
    Pahl PM; Horwitz LD
    Cancer Invest; 2005; 23(8):683-91. PubMed ID: 16377587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progresses in TCM metal-based antitumour agents.
    Chen ZF; Liang H
    Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iron chelators for the treatment of cancer.
    Yu Y; Gutierrez E; Kovacevic Z; Saletta F; Obeidy P; Suryo Rahmanto Y; Richardson DR
    Curr Med Chem; 2012; 19(17):2689-702. PubMed ID: 22455580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
    Nguyen M; Robert A; Sournia-Saquet A; Vendier L; Meunier B
    Chemistry; 2014 May; 20(22):6771-85. PubMed ID: 24797103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions.
    Planalp RP; Przyborowska AM; Park G; Ye N; Lu FH; Rogers RD; Broker GA; Torti SV; Brechbiel MW
    Biochem Soc Trans; 2002 Aug; 30(4):758-62. PubMed ID: 12196188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expanding horizons in iron chelation and the treatment of cancer: role of iron in the regulation of ER stress and the epithelial-mesenchymal transition.
    Lane DJ; Mills TM; Shafie NH; Merlot AM; Saleh Moussa R; Kalinowski DS; Kovacevic Z; Richardson DR
    Biochim Biophys Acta; 2014 Apr; 1845(2):166-81. PubMed ID: 24472573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Water soluble glucose derivative of thiocarbohydrazone acts as ionophore with cytotoxic effects on tumor cells.
    Bonaccorso C; Grasso G; Musso N; Barresi V; Condorelli DF; La Mendola D; Rizzarelli E
    J Inorg Biochem; 2018 May; 182():92-102. PubMed ID: 29452884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of Tetradentate Copper Chelators as Potential Anti-Alzheimer Agents.
    Zhang W; Huang D; Huang M; Huang J; Wang D; Liu X; Nguyen M; Vendier L; Mazères S; Robert A; Liu Y; Meunier B
    ChemMedChem; 2018 Apr; 13(7):684-704. PubMed ID: 29420864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and characterization of ligational behavior of curcumin drug towards some transition metal ions: chelation effect on their thermal stability and biological activity.
    Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():326-37. PubMed ID: 23318777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coinage metal complexes against breast cancer.
    Biersack B; Ahmad A; Sarkar FH; Schobert R
    Curr Med Chem; 2012; 19(23):3949-56. PubMed ID: 22780959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bis(thiosemicarbazones) as bifunctional chelators for the room temperature 64-copper labeling of peptides.
    Hueting R; Christlieb M; Dilworth JR; García Garayoa E; Gouverneur V; Jones MW; Maes V; Schibli R; Sun X; Tourwé DA
    Dalton Trans; 2010 Apr; 39(15):3620-32. PubMed ID: 20354615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases.
    Ma DL; Wu C; Li G; Yung TL; Leung CH
    J Mater Chem B; 2020 Jun; 8(22):4715-4725. PubMed ID: 32100789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iron chelators in cancer chemotherapy.
    Buss JL; Greene BT; Turner J; Torti FM; Torti SV
    Curr Top Med Chem; 2004; 4(15):1623-35. PubMed ID: 15579100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc ionophores: chemistry and biological applications.
    Scavo S; Oliveri V
    J Inorg Biochem; 2022 Mar; 228():111691. PubMed ID: 34929542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.